Analysis for CRH

📈 Growth & Financial Trajectory

Eight quarters show Revenues rising from $8,870,000,000 in 2024 Q3 to $10,777,000,000 in 2026 Q2, a ~21-22% gain, with a mid-period dip in Q4 2025 to about $9,416,000,000. Net Income improved from a loss of about $98,000,000 in 2024 Q3 to about $1,511,000,000 in 2026 Q2, reflecting stronger profitability and operating leverage despite quarterly fluctuations.

💰 Margins & Cash Flow

Gross margin hovered in the mid-30s to low-40s (roughly 36%-42%), with a peak around 42% in 2026 Q1, supporting solid profitability. Operating margin ranged roughly 11%-22%, dipping in 2026 Q1 to about 15% as costs or mix shifted. Cash flow from operations was consistently positive across quarters, with net cash from operating activities typically in the 1.0–2.7B range; investing cash flow was negative, and financing/investing activities often offset net results, yielding modest overall cash flow in some periods.

🛡️ Balance Sheet & Liquidity

Total assets sit near $58.6B (Q2 2026), with liabilities around $33.0B and equity about $25.1B, indicating solid capitalization. Current assets ≈ $15.8B vs current liabilities ≈ $9.98B; liquidity remains comfortable. Long-term debt around the mid-to-high teens, leaving a reasonable leverage profile.

⚠️ Key Drivers & Risks

• Drivers: Continued top-line growth and favorable gross margin trends; solid cash generation supports balance sheet resilience.
• Risks: Margin volatility from mix or cost pressures; cyclicality and macro exposure could compress earnings.